Nuchev Limited Logo

Nuchev Limited

NUC.AX

(1.8)
Stock Price

0,12 AUD

-81% ROA

-109.95% ROE

-1.01x PER

Market Cap.

21.950.850,00 AUD

0.58% DER

0% Yield

-67.39% NPM

Nuchev Limited Stock Analysis

Nuchev Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Nuchev Limited Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.81x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a minimal amount of debt (2%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 Revenue Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

4 Net Profit Growth

Throughout the last three years, this company has experienced consistent net profit growth, reflecting a robust financial performance and making it an attractive investment prospect.

5 Graham Number

Based on the Graham number, this company's stock price appears to be lower than its intrinsic value, signaling a potentially favorable investment choice.

6 ROE

The stock's ROE indicates a negative return (-61.49%) on shareholders' equity, suggesting poor financial performance.

7 ROA

The stock's ROA (-57.47%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (0), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Nuchev Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Nuchev Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Sell
4 Stoch RSI Sell

Nuchev Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Nuchev Limited Revenue
Year Revenue Growth
2017 2.544.357
2018 3.441.257 26.06%
2019 9.499.278 63.77%
2020 17.763.252 46.52%
2020 17.763.252 0%
2021 10.899.342 -62.98%
2022 9.723.809 -12.09%
2023 8.791.601 -10.6%
2024 18.968.112 53.65%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Nuchev Limited Research and Development Expenses
Year Research and Development Expenses Growth
2017 0
2018 117.684 100%
2019 151.253 22.19%
2020 0 0%
2020 214.649 100%
2021 232.051 7.5%
2022 434.825 46.63%
2023 7.428 -5753.86%
2024 86.124 91.38%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Nuchev Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2017 1.600.000
2018 1.307.358 -22.38%
2019 1.250.034 -4.59%
2020 8.259.706 84.87%
2020 8.259.706 0%
2021 6.805.267 -21.37%
2022 6.096.319 -11.63%
2023 7.039.714 13.4%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Nuchev Limited EBITDA
Year EBITDA Growth
2017 -8.334.149
2018 -9.233.280 9.74%
2019 -7.958.040 -16.02%
2020 -10.174.557 21.78%
2020 -9.872.601 -3.06%
2021 -11.539.354 14.44%
2022 -10.198.670 -13.15%
2023 -7.999.760 -27.49%
2024 -15.506.800 48.41%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Nuchev Limited Gross Profit
Year Gross Profit Growth
2017 -685.402
2018 -2.440.715 71.92%
2019 -945.640 -158.1%
2020 5.640.880 116.76%
2020 5.640.880 0%
2021 3.203.167 -76.1%
2022 2.777.403 -15.33%
2023 1.655.231 -67.8%
2024 -1.137.312 245.54%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Nuchev Limited Net Profit
Year Net Profit Growth
2017 -9.679.724
2018 -14.074.385 31.22%
2019 -13.499.836 -4.26%
2020 -10.059.233 -34.2%
2020 -12.395.813 18.85%
2021 -13.739.962 9.78%
2022 -11.813.449 -16.31%
2023 -8.806.694 -34.14%
2024 -15.582.460 43.48%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Nuchev Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2017 0
2018 0 0%
2019 0 0%
2020 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Nuchev Limited Free Cashflow
Year Free Cashflow Growth
2017 -13.880.279
2018 -10.614.332 -30.77%
2019 -8.848.285 -19.96%
2020 -15.092 -58532.86%
2020 -10.755.116 99.86%
2021 -9.863.278 -9.04%
2022 -11.619.916 15.12%
2023 -3.383.763 -243.4%
2024 -2.200.069 -53.8%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Nuchev Limited Operating Cashflow
Year Operating Cashflow Growth
2017 -13.158.071
2018 -9.064.392 -45.16%
2019 -8.636.477 -4.95%
2020 0 0%
2020 -10.694.750 100%
2021 -9.494.376 -12.64%
2022 -11.614.545 18.25%
2023 -3.256.929 -256.61%
2024 -2.192.048 -48.58%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Nuchev Limited Capital Expenditure
Year Capital Expenditure Growth
2017 722.208
2018 1.549.940 53.4%
2019 211.808 -631.77%
2020 15.092 -1303.54%
2020 60.366 75%
2021 368.902 83.64%
2022 5.371 -6768.4%
2023 126.834 95.77%
2024 8.021 -1481.27%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Nuchev Limited Equity
Year Equity Growth
2017 2.321.108
2018 -4.228.621 154.89%
2019 32.800.000 112.89%
2020 25.275.400 -29.77%
2021 26.690.902 5.3%
2022 15.827.793 -68.63%
2023 12.818.210 -23.48%
2024 14.752.556 13.11%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Nuchev Limited Assets
Year Assets Growth
2017 17.943.024
2018 17.145.421 -4.65%
2019 34.400.000 50.16%
2020 27.509.755 -25.05%
2021 28.309.353 2.82%
2022 17.747.468 -59.51%
2023 15.324.600 -15.81%
2024 20.092.957 23.73%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Nuchev Limited Liabilities
Year Liabilities Growth
2017 15.621.916
2018 21.374.042 26.91%
2019 1.600.000 -1235.88%
2020 2.234.355 28.39%
2021 1.618.451 -38.06%
2022 1.919.675 15.69%
2023 2.506.390 23.41%
2024 5.340.401 53.07%

Nuchev Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.22
Net Income per Share
-0.15
Price to Earning Ratio
-1.01x
Price To Sales Ratio
1.15x
POCF Ratio
-2.23
PFCF Ratio
-3.73
Price to Book Ratio
0.88
EV to Sales
0.77
EV Over EBITDA
-1.16
EV to Operating CashFlow
-2.51
EV to FreeCashFlow
-2.49
Earnings Yield
-0.99
FreeCashFlow Yield
-0.27
Market Cap
0,02 Bil.
Enterprise Value
0,01 Bil.
Graham Number
0.75
Graham NetNet
0.07

Income Statement Metrics

Net Income per Share
-0.15
Income Quality
0.45
ROE
-1.1
Return On Assets
-0.64
Return On Capital Employed
-0.85
Net Income per EBT
1
EBT Per Ebit
1
Ebit per Revenue
-0.67
Effective Tax Rate
-0

Margins

Sales, General, & Administrative to Revenue
0.1
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
-0
Gross Profit Margin
-0.01
Operating Profit Margin
-0.67
Pretax Profit Margin
-0.67
Net Profit Margin
-0.67

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.07
Free CashFlow per Share
-0.07
Capex to Operating CashFlow
-0.01
Capex to Revenue
0
Capex to Depreciation
0.2
Return on Invested Capital
-0.87
Return on Tangible Assets
-0.81
Days Sales Outstanding
40.82
Days Payables Outstanding
79.57
Days of Inventory on Hand
94.83
Receivables Turnover
8.94
Payables Turnover
4.59
Inventory Turnover
3.85
Capex per Share
0

Balance Sheet

Cash per Share
0,09
Book Value per Share
0,17
Tangible Book Value per Share
0.12
Shareholders Equity per Share
0.17
Interest Debt per Share
0
Debt to Equity
0.01
Debt to Assets
0
Net Debt to EBITDA
0.58
Current Ratio
3.08
Tangible Asset Value
0,01 Bil.
Net Current Asset Value
0,01 Bil.
Invested Capital
14870867
Working Capital
0,01 Bil.
Intangibles to Total Assets
0.21
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
4529224
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Nuchev Limited Dividends
Year Dividends Growth

Nuchev Limited Profile

About Nuchev Limited

Nuchev Limited, a health and nutrition solutions company, produces, markets, and sells goat milk-based infant formula and nutritional products to consumers in Australia, China, and Vietnam. The company provides toddler nutrition, goat nutritional powder, and health and well-being products under the Oli6 brand. It offers its products through retailers and e-commerce platforms. Nuchev Limited was founded in 2013 and is headquartered in Melbourne, Australia.

CEO
Mr. Michael Myers
Employee
0
Address
Level 10
Melbourne, 3004

Nuchev Limited Executives & BODs

Nuchev Limited Executives & BODs
# Name Age
1 Ms. Helen Hovenga B.A., M.B.A.
Head of Human Resources
70
2 Ms. Tamara Monica Barr
Company Secretary
70
3 Mr. Michael Myers
Chief Executive Officer
70
4 Mr. Eddie MacDonald BCom, CPA, MBA
Chief Financial Officer
70
5 Mr. Scott Koetsier
Head of Sales & Business Development
70
6 Mr. Ben Dingle
Founder & Chairman of the Board
70

Nuchev Limited Competitors